TransMedics: A Very Expensive Growth Stock

Morsa Images Investment Thesis TransMedics Group, Inc. (NASDAQ:TMDX) is an underappreciated medical technology stock that's signature invention, the Organ Care System, helps better transport donor organs by keeping them in warm fluid that mimics the human body. The company has seen phenomenal growth, reporting 159% YoY and 27% QoQ revenue growth in its most recent Q3 2023 quarter. TransMedics is a 4% position for us. We were buyers in August-November 2023 with an average price of $59, but the stock ran up f ...